• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Now is the Time to Address Substance Use Disorders in Primary Care.现在是时候在初级保健中解决物质使用障碍问题了。
Ann Fam Med. 2017 Jul;15(4):306-308. doi: 10.1370/afm.2111.
2
Geographic and specialty distribution of US physicians trained to treat opioid use disorder.接受过治疗阿片类药物使用障碍培训的美国医生的地理分布和专业分布。
Ann Fam Med. 2015 Jan-Feb;13(1):23-6. doi: 10.1370/afm.1735.
3
Addiction disorders.成瘾障碍。
Med Clin North Am. 2014 Sep;98(5):1097-122. doi: 10.1016/j.mcna.2014.06.008.
4
How the paediatric workforce can address the opioid crisis.儿科医疗人员如何应对阿片类药物危机。
Lancet. 2016 Sep 24;388(10051):1260-1. doi: 10.1016/S0140-6736(16)31573-2.
5
Cognitive Behavioral Therapy Improves Treatment Outcomes for Prescription Opioid Users in Primary Care Buprenorphine Treatment.认知行为疗法改善了初级保健丁丙诺啡治疗中处方阿片类药物使用者的治疗效果。
J Subst Abuse Treat. 2016 Dec;71:54-57. doi: 10.1016/j.jsat.2016.08.016. Epub 2016 Sep 2.
6
Where Is Buprenorphine Dispensed to Treat Opioid Use Disorders? The Role of Private Offices, Opioid Treatment Programs, and Substance Abuse Treatment Facilities in Urban and Rural Counties.用于治疗阿片类药物使用障碍的丁丙诺啡在哪里配发？私人诊所、阿片类药物治疗项目以及城乡县的药物滥用治疗设施所起的作用。
Milbank Q. 2015 Sep;93(3):561-83. doi: 10.1111/1468-0009.12137.
7
Substance use, treatment, and demographic characteristics of pregnant women entering treatment for opioid use disorder differ by United States census region.因阿片类物质使用障碍而接受治疗的孕妇的物质使用情况、治疗情况及人口统计学特征因美国人口普查地区而异。
J Subst Abuse Treat. 2017 May;76:58-63. doi: 10.1016/j.jsat.2017.01.011. Epub 2017 Feb 1.
8
Substance use and recovery: charting a course toward optimism. Interview by Kathleen R Delaney.物质使用与康复：绘制通往乐观的路线。凯瑟琳·R·德莱尼访谈
Arch Psychiatr Nurs. 2006 Dec;20(6):288-90. doi: 10.1016/j.apnu.2006.08.001.
9
Painkillers fuel growth in drug addiction. Opioid overdoses now kill more people than cocaine or heroin.止痛药助长了药物成瘾的增长。现在，阿片类药物过量致死的人数比可卡因或海洛因更多。
Harv Ment Health Lett. 2011 Jan;27(7):4-5.
10
Treating opioid addiction with buprenorphine-naloxone in community-based primary care settings.在社区基层医疗环境中使用丁丙诺啡-纳洛酮治疗阿片类药物成瘾。
Ann Fam Med. 2007 Mar-Apr;5(2):146-50. doi: 10.1370/afm.665.

引用本文的文献

1
Expectations and needs of people with illicit substance use disorders in general practice: a qualitative study in Belgium.一般实践中滥用药物者的期望和需求：比利时的定性研究。
BMC Prim Care. 2024 Aug 14;25(1):303. doi: 10.1186/s12875-024-02493-3.
2
Barriers and Facilitators to Using a Clinical Decision Support Tool for Opioid Use Disorder in Primary Care.在基层医疗中使用临床决策支持工具治疗阿片类药物使用障碍的障碍和促进因素。
J Am Board Fam Med. 2024 Aug 14;37(3):389-398. doi: 10.3122/jabfm.2023.230308R1.
3
Trauma exposure across the lifespan among individuals engaged in treatment with medication for opioid use disorder: differences by gender, PTSD status, and chronic pain.接受阿片类药物使用障碍药物治疗的个体在其一生中所经历的创伤：按性别、创伤后应激障碍状态和慢性疼痛的差异
Subst Abuse Treat Prev Policy. 2024 May 3;19(1):25. doi: 10.1186/s13011-024-00608-8.
4
Trauma Exposure Across the Lifespan among Individuals Engaged in Treatment with Medication for Opioid Use Disorder: Differences by Gender, PTSD Status, and Chronic Pain.接受阿片类药物使用障碍药物治疗的个体在其一生中所经历的创伤：按性别、创伤后应激障碍状态和慢性疼痛划分的差异
Res Sq. 2023 Dec 19:rs.3.rs-3750143. doi: 10.21203/rs.3.rs-3750143/v1.
5
The Association Between Depression and Substance Use Among Primary Care Patients With Comorbid Medical and Behavioral Health Conditions.患有共病的医疗和行为健康状况的初级保健患者中抑郁与物质使用之间的关联。
J Prim Care Community Health. 2023 Jan-Dec;14:21501319231200302. doi: 10.1177/21501319231200302.
6
A randomized, parallel group, pragmatic comparative-effectiveness trial comparing medication-assisted treatment induction methods in primary care practices: The HOMER study protocol.一项在初级保健实践中比较药物辅助治疗诱导方法的随机、平行分组、实用比较有效性试验：HOMER 研究方案。
PLoS One. 2023 Sep 8;18(9):e0290388. doi: 10.1371/journal.pone.0290388. eCollection 2023.
7
Exploring Barriers and Facilitators to Integrating a Harm Reduction Approach to Substance Use in Three Medical Settings.探讨在三个医疗环境中整合减少物质使用伤害方法的障碍和促进因素。
J Gen Intern Med. 2023 Nov;38(15):3273-3282. doi: 10.1007/s11606-023-08231-2. Epub 2023 May 25.
8
Primary care provider confidence in addressing opioid use disorder: A concept analysis.基层医疗服务提供者处理阿片类药物使用障碍的信心：概念分析。
Res Nurs Health. 2023 Apr;46(2):263-273. doi: 10.1002/nur.22294. Epub 2023 Jan 7.
9
Systematic review of guidelines for managing physical health during treatment for substance use disorders: Implications for the alcohol and other drug workforce.系统评价治疗物质使用障碍期间管理身体健康的指南：对酒精和其他药物工作人员的影响。
Drug Alcohol Rev. 2022 Sep;41(6):1367-1390. doi: 10.1111/dar.13504. Epub 2022 Jun 28.
10
Nudging primary care providers to expand the opioid use disorder workforce.推动基层医疗服务提供者扩大阿片类药物使用障碍治疗队伍。
Health Serv Res. 2022 Apr;57(2):403-410. doi: 10.1111/1475-6773.13894. Epub 2021 Nov 7.

本文引用的文献

1
Disenfranchised Grief and Physician Burnout.被剥夺的悲伤和医生倦怠。
Ann Fam Med. 2017 Jul;15(4):375-378. doi: 10.1370/afm.2074.
2
Denial: The Greatest Barrier to the Opioid Epidemic.否认：阿片类药物泛滥的最大障碍。
Ann Fam Med. 2017 Jul;15(4):372-374. doi: 10.1370/afm.2057.
3
Barriers Rural Physicians Face Prescribing Buprenorphine for Opioid Use Disorder.农村医生在开具丁丙诺啡治疗阿片类药物使用障碍方面面临的障碍。
Ann Fam Med. 2017 Jul;15(4):359-362. doi: 10.1370/afm.2099.
4
Mortality Associated With Time in and Out of Buprenorphine Treatment in French Office-Based General Practice: A 7-Year Cohort Study.法国基层医疗点中丁丙诺啡治疗期间和治疗结束后的死亡率：一项 7 年队列研究。
Ann Fam Med. 2017 Jul;15(4):355-358. doi: 10.1370/afm.2098.
5
Delivery of Brief Interventions for Heavy Drinking in Primary Care: Outcomes of the ODHIN 5-Country Cluster Randomized Trial.在初级保健中提供针对重度饮酒的简短干预措施：ODHIN 五国集群随机试验的结果。
Ann Fam Med. 2017 Jul;15(4):335-340. doi: 10.1370/afm.2051.
6
Medication-Assisted Treatment Should Be Part of Every Family Physician's Practice: No.药物辅助治疗应成为每位家庭医生业务的一部分：不。
Ann Fam Med. 2017 Jul;15(4):310-312. doi: 10.1370/afm.2102.
7
Medication-Assisted Treatment Should Be Part of Every Family Physician's Practice: Yes.药物辅助治疗应成为每位家庭医生诊疗工作的一部分：答案是肯定的。
Ann Fam Med. 2017 Jul;15(4):309-310. doi: 10.1370/afm.2103.
8
Project ECHO (Extension for Community Healthcare Outcomes): A new model for educating primary care providers about treatment of substance use disorders.社区医疗成果推广计划（ECHO）：一种针对初级保健提供者开展物质使用障碍治疗教育的新模式。
Subst Abus. 2016;37(1):20-4. doi: 10.1080/08897077.2015.1129388.
9
Office-Based Opioid Treatment with Buprenorphine (OBOT-B): Statewide Implementation of the Massachusetts Collaborative Care Model in Community Health Centers.基于办公室的丁丙诺啡阿片类药物治疗（OBOT-B）：马萨诸塞州协作护理模式在社区卫生中心的全州实施情况
J Subst Abuse Treat. 2016 Jan;60:6-13. doi: 10.1016/j.jsat.2015.06.010. Epub 2015 Jun 26.
10
Geographic and specialty distribution of US physicians trained to treat opioid use disorder.接受过治疗阿片类药物使用障碍培训的美国医生的地理分布和专业分布。
Ann Fam Med. 2015 Jan-Feb;13(1):23-6. doi: 10.1370/afm.1735.

Now is the Time to Address Substance Use Disorders in Primary Care.

作者信息

Saitz Richard, Daaleman Timothy P

机构信息

Boston University School of Public Health, Boston, Massachusetts

Department of Family Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.

出版信息

Ann Fam Med. 2017 Jul;15(4):306-308. doi: 10.1370/afm.2111.

DOI:10.1370/afm.2111
PMID:28694263
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5505446/
Abstract
摘要